Genetic focus: investigated genetic mutations, single-nucleotide polymorphisms, or gene pathways (e.g., WNT/β-catenin, Notch, RUNX2, COL1A1, VDR) associated with the onset, severity, or progression of osteoporosis. This evidence concerns the gene RUNX2 and osteoporosis.